This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
Avatar

ASCO® 2024 Insights: "Analyses of TTX-080, a First-in-Class HLA-G Antagonist, in Combination With Cetuximab in Patients With mCRC and HNSCC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susanna Ulahannan
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susanna Ulahannan
28 views
July 3, 2024
0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: Head & Neck Videos

19:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Tri…

Feat. K. Kerrigan
08:06
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor T…

Feat. D. Ziegler
06:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Petosemtamab With Pembro as 1L Treatment …

Feat. C. Perez
View All

Related Content

AUTOPLAY
Fred Hutchinson Cancer Center

Head & Neck Virtual Webinar Series #1

Thu, Sep 19, 2024
14:57
Penn Medicine

The Radiologist's Approach to Assessing Cancer Risk of Thyroid …

Feat. J. Langer
27:04
Fengting Yan

Cancer Screening Molecular Tools

21:12
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Ca…

Feat. N. Saba
03:08
Nicholas DeVito

The Importance of 1L Biomarkers in CRC

29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
27:51
Keck School of Medicine of USC

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Feat. R. Michael Tuttle
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

Feat. V. Subbiah
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
15:51
Total Health

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Feat. A. Grothey
24:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckM…

Feat. R. Kim, T. Biachi
14:49
Vivek Subbiah

Year in Review: Precision Medicine

13:29
Ibrahim Sahin

Treating KRAS-Mutated mCRC

25:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "News in Head&Neck Cancers"

Feat. P. Bossi
26:19
Ammar Sukari

Nasopharyngeal Carcinoma: Clinical Overview & Disease Management

18:07
Nebraska Oncology Society

NOS ASCO® 2023 Review: Nasopharynx Cancer

Feat. E. Sherman
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
15:45
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal …

Feat. S. Chakrabarti, A. Shreenivas
09:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini
42:49
Yale Cancer Center

Parathyroid Disease and Tumors

Feat. C. Gibson
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde